Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 39

Intra Aortic Balloon

Counterpulsation

Dr N. Seetaramji
Registrar,
Dept. Of Anaesthesiology,
Wockhardt Hospital.
History

 Willem Kolff, Stephen Topaz, et al


conceived this procedure at the
Cleveland Clinic in 1961
 Kantrowitz applied it to patients in 1967.
JAMA 203:135, 1968
Concepts of Counterpulsation
 The balloon is phasically pulsed in
counterpulsation to the patient’s cardiac
cycle (IABC)
 IABP has no ‘inotropic’ action; does not
directly increase contractility.
 Primarily benefits the left ventricle, although
the diastolic augmentation may improve
coronary flow to both ventricals.
Some Basics of
Myocardial O2 Supply/Delivery
 Ischemic heart has maximally dilated arteries. Perfusion
is then directly related to perfusion pressure.
 Coronary perfusion occurs predominately during diastole
 Increasing diastolic time increases coronary blood flow
 Major resistance to (subendocardial) coronary blood flow
during diastole is LVEDP such that...
 CPP=AoDP-LVEDP
 AoDP and LVEDP are dynamic values
 Windkessel Effect
Contd.
 Overlapping the aortic pressure and LV pressure
curves gives a visual representation of the pressure
gradient.
 This gradient over the diastolic time cycle is
described as the Diastolic Pressure Time Index
(DPTI)
 Area within the DPTI is directly correlated with O2
availability to the myocardium (supply)
Some Basics of
MVO2/Demand

 HR, contractility, wall tension (50% of MVO2 at rest).


 Laplace’s law T=Pr/2h
 Intraventricular pressure is a modifiable variable.
 IVP greatest during systole (LVSP).
 LVSP is a dynamic value continually changing throughout
systole and altering wall tension as this occurs.
 Area under the LVSP tracing is represented by the Tension
Time Index (TTI) and is directly correllated to wall tension and
MVO2.
Contd.
 Increasing systole time (HR) or peak LV systolic
pressure increases the TTI and subsequently MVO2
 Conversely, lowering the AoEDP (decreased
afterload) decreases the pressure the LV must
overcome to eject blood and lowers the TTI
 The Endocardial Viability Ratio relates the
relationship between myocardial O2 supply and
demand and is defined by EVR=DPTI/TTI
(supply/demand).
Windkessel Effect
 Potential energy stored in aortic root during systole
 Converted to kinetic energy with elastic recoil of
aortic root
 Increases diastolic pressure/flow during early
diastole
 Less affect with hypovolemia or noncompliant
aortas
 Noted on the A-line tracing as the dicrotic notch
IABP- how does it work?
 IABP does not ‘pump’ blood per se in contrast to a
VAD.
 Requires a functioning, beating heart.
 IABP serves as an external source of energy to
allow the sick heart to pump more efficiently.
 Does this via afterload reduction and diastolic
augmentation.
 Net result is an increased DO2, decreased MVO2,
and an increased CO.
Indications
 Pump failure (reversible)
- AMI ; Ohman EM et al (1994), Kono T et al (1996).
(JACC Guidelines 1996 on IABP use in AMI)
- cardiogenic shock
-progressive deterioration despite pharmacologic
support
- Reversible mech. effects
-VSD, Ac. Mitral Regurgitation.
- Unstable Angina / PTCA.
Contd.
 Cardiac transplant patient
-as a bridge to transplantation
-post transplant support
 Prophylactic preoperative use
 Aide to separate from CPB
 Transport to tertiary centre.
 Post traumatic Heart Failure.
 Supporting High Risk Non-Cardiac Surgery.
Contraindications

 Thoracic or abdominal aortic aneurysm


 Aortic dissection
 Aortic insufficiency
 ? Severe pre-existing vascular disease,
presence of iliofemoral grafts.
 ? Prosthetic aortic graft
Balloon Selection
“Datascope”
Patient’s IABP IABP
Height Volume Length

(cm) (cc)
(mm)

< 152 25 174


153 – 162 34 219
163 – 183 40 263
Contd.
“Arrow”

Patient’s IABP IABP


BSA Volume Length
(cm) (cc)
(mm)

< 1.8 30 230


> 1.8 40 262
Placement.
 6.5 Fr Catheter, 8 Fr Introducer, Heparinisation, etc.
 If Pulses not felt, Ankle arm index.
 Placed percutaneously or surgically with or without a
sheath via the femoral artery; Seldinger technique.
 Advanced into aorta under flouroscopy until the tip is
about 2 cm distal to the origin of the left subclavian
artery.
 Catheter locations more proximal than this compromise
flow to the vessels of the aortic arch.
 More distal locations attenuate the hemodynamic benefits
of the IABP and can potentially compromise renal blood
flow.
Contd.

 Palpate the Left Radial artery pulse.


 Confirm position with X’ray Chest/TEE.
 Keep aPTT @ twice control.
 Check circulation to the relevent limb: Doppler
ankle pressure < 40 mmHg / ankle arm index < 0.25 indicate
circulatory impairement.
 Follow Sr Creatinine & urine output daily
 Compartment syndrome, watch for.
Determinants of IABP efficiency
 Ideal balloon volume causes maximal emptying of
LV without causing retrograde flow from the
coronary vasculature and vessels of the aortic arch.
 Balloon should occlude 75-90% of the aortic cross-
sectional area during inflation.
 CO2 vs Helium
 Efficiency if IABC is critically dependent on the
timing of both inflation and deflation.
IAPB Triggering
 IABP requires a trigger to determine systole and diastole.
 ECG or arterial waveform.
 ECG directly from the patient to the pump or the pump
can slave off the bedside monitor.
 T-wave default. Electrical index of diastole. Deflation
occurs prior to the next QRS (during PR interval).
 Timing is manually fine-tuned according to the aortic
pressure waveform (more representative of mechanical
events).
 External Pacemaker – Danger ?/Emergency use.
 Internal impulse generation from console
Early inflation: Aortic valve
still open, ↑Ventricular Workload.
Late Inflation: ↓rise in diastolic
aortic root pressure,
ineffective coronary perfusion.
Early Deflation: shortens
diastole, ↓coronary perfusion time
Late Deflation: balloon still
inflated, ↑ ventricular afterload.
IAB monitors self
 Volume & pressure in the balloon.
 Leaks in driving gas.
 Loss of ECG/Arterial signal
 Arrhythmia detection & change in Heart
rate.
 Improper deflation of the IAB.
Limitations of IABC

 Heart Rate, 130/min ?


 Arrhythmias (non-sinus rhythms)
 Hypovolemia
 Systolic pressure: 40 mmHg for pressure trigger.
 Cardiac Output: Minimum CI of 1.2 to 1.4
ltrs/min/m2.
Diastolic Augmentation
 Balloon inflation at the onset of diastole which is
correllated to aortic valve closure (mechanical event).
 Displacement of blood within the aorta to areas proximal
and distal to the balloon. Termed “compartmentilization”.
 Proximal compartment consists of branches of aortic arch
(carotids) and coronary vasculature.
 Diastolic balloon inflation augments cerebral and
coronary perfusion.
 Increased DPTI and EVR.
 ‘Exaggerated’ Windkessel Effect.
Afterload Reduction
 Optimal balloon deflation occurs just prior to the
opening of the aortic valve; during early
isovolemic contraction.
 Abruptly decreases intraaortic volume
 AoEDP is acutely decreased (afterload reduction).
 AoV opens sooner during cardiac cycle lending
more time for ventricular ejection
 Overall result is a larger SV (CO).
 A lower peak LVSP decreases the TTI which
leads to a decrease MVO2 and an icrease in the
EVR.
BP & IABP
 Normal BP has two reference points- SBP & DBP
 With a pump set at 1:2 you have 5 different reference
points.
 Net effect:
*SBP following an augmented beat will be lower than
SBP following an unassisted beat.
*AoEDP following an augmented beat will be lower than
AoEDP following an unassisted beat.
*Peak diastolic augmented pressure will be integrated into
the pressure reading on the arterial line. Overall BP as
read by A-line (number you see) should increase
BP & IABP
Weaning

 Frequency ratio weaning (1:1, 1:2, 1:3,


etc.).
 Volume weaning (more physiologic?)

 Stop Heparin 2 hrs & Platelet count

> 60,000/mm3 before IAB explantation.


Risk of IABC
 Reported complication rates vary, but in
general range about 20-30% of all IABP’s
placed.
 Factors which predispose to a higher
complication rate include age, pre-existing
vascular disease, duration of IABP, DM,
HTN, obesity, and vasopressor therapy.
Complications : During Insertion
 Failure: 6%, even with 8Fr sheath.
 Arterial dissection, perforation.
 Bleeding
 Misplacement to LV, Subclavian, Lt.
common carotid, contralateral Femoral
arteries were reported. Isner JM (1980)
Complications: Balloon in situ
 Limb Ischemia/compartment syndrome
 Infection
 Thrombocytopenia/hemolytic anemia
 Embolization of platelet aggregates
 Rupture of balloon/gas embolism
 IAB Entrapment
  complications with Size ≥ 9.5 Fr and balloon
in situ for > 48 hrs.
Complications: After Removal

 Surgical explantation in coagulopathy


 Hematoma
 False Aneurism
 Arterio-venous fistula

You might also like